Antenatal diagnosis by DNA analysis: Current status, future developments? and a few unanswered questions

BioEssays ◽  
1985 ◽  
Vol 2 (5) ◽  
pp. 196-201 ◽  
Author(s):  
B. R. Jordan
1987 ◽  
Vol 146 (9) ◽  
pp. 462-465
Author(s):  
Ronald J. Trent ◽  
Rhonda G. Warr ◽  
Francesca Volpato ◽  
John C. Anderson ◽  
Antheunis Boogert

2021 ◽  
Vol 136 (2) ◽  
Author(s):  
A. Redondo-Cubero ◽  
M. J. G. Borge ◽  
N. Gordillo ◽  
P. C. Gutiérrez ◽  
J. Olivares ◽  
...  

2012 ◽  
Vol 10 (H16) ◽  
pp. 137-137 ◽  

The Joint Discussion 5 entitled "From Meteors and Meteorites to their Parent Bodies: Current Status and Future Developments" within the IAU GA 2012 was organized with the coordination of the IAU Division III Planetary Systems Sciences and the IAU Commission N. 22 Meteors, Meteorites & Interplanetary Dust, together with the supports by Divisions I Fundamental Astronomy, Division XII Union-Wide Activities, Commission 4 Ephemerides, Commission 6 Astronomical Telegrams, Commission 8 Astrometry, Commission 15 Physical Study of Comets & Minor Planets, and Commission 20 Positions & Motions of Minor Planets, Comets & Satellites.


Cancers ◽  
2019 ◽  
Vol 11 (3) ◽  
pp. 399 ◽  
Author(s):  
Angelica Petrillo ◽  
Luca Pompella ◽  
Giuseppe Tirino ◽  
Annalisa Pappalardo ◽  
Maria Maddalena Laterza ◽  
...  

Gastric cancer (GC) is the fifth-most common cancer worldwide and an important cause of cancer-related-death. The growing knowledge of its molecular pathogenesis has shown that GC is not a single entity, but a constellation of different diseases, each with its own molecular and clinical characteristics. Currently, surgery represents the only curative approach for localized GC, but only 20% of patients (pts) showed resectable disease at diagnosis and, even in case of curative resection, the prognosis remains poor due to the high rate of disease relapse. In this context, multimodal perioperative approaches were developed in western and eastern countries in order to decrease relapse rates and improve survival. However, there is little consensus about the optimal treatment for non-metastatic GC. In this review, we summarize the current status and future developments of perioperative chemotherapy in resectable GC, attempting to find clear answers to the real problems in clinical practice.


2019 ◽  
Vol 20 (2) ◽  
pp. 255-264 ◽  
Author(s):  
Erik Kouba ◽  
Antonio Lopez-Beltran ◽  
Rodolfo Montironi ◽  
Francesco Massari ◽  
Kun Huang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document